Biogen Idec, Inc. (Massachusetts) (BIIB) Appoints Spyros Artavanis-Tsakonas Chief Scientific Officer
5/23/2013 7:54:15 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Biogen Idec (NASDAQ:BIIB) today announced that Spyros Artavanis-Tsakonas, Ph.D., has been named the company’s Chief Scientific Officer (CSO). Dr. Artavanis-Tsakonas had served as interim CSO while on sabbatical from Harvard Medical School. He will now continue in this role in a permanent capacity, and will also lead the company’s research strategy, capabilities and discovery platforms.
Help employers find you! Check out all the jobs and post your resume.